Latest News
Wed, 21 Dec 2011
Impax Pharmaceuticals Submits New Drug Application for IPX066 in Parkinson’s Disease
Mon, 19 Dec 2011Impax Pharmaceuticals Initiates Phase IIb Trial of IPX159 in Restless Legs Syndrome
Mon, 15 Aug 2011View All
Pipeline
Utilizing formulation and drug delivery expertise to offer innovative CNS products.
Therapeutic Research
One area of focus is improving on current standards of Parkinson’s therapy.
